XKRX
214680
Market cap46mUSD
Oct 08, Last price
3,760.00KRW
1D
-1.31%
1Q
292.08%
Jan 2017
73.67%
IPO
26.81%
Name
DR Tech Corp
Chart & performance
P/E
—
P/S
0.54
EPS
—
Div yield, %
—
Shrs. gr., 5y
-9.11%
Rev. gr., 5y
16.04%
Revenues
116.30b
+19.21%
Net income
-24.03b
L+24.56%
CFO
-20.13b
L+25.63%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
DRTECH Corporation focuses on the development and global distribution of flat-panel X-ray detectors for digital radiography, serving markets both within South Korea and abroad. Their extensive product line includes detectors customized for diverse applications such as general medical imaging, mammography, dynamic studies, dental diagnostics, veterinary care, and industrial inspections. Furthermore, the company offers integrated imaging solutions, which incorporate specialized user interface software, dual-energy X-ray capabilities, artificial intelligence-powered image processing, advanced image reconstruction techniques, and AI-based Computer-Aided Detection (CAD). DRTECH also provides complete radiography, mammography, and C-arm systems. Founded in 2000, the company's headquarters are located in Seongnam-si, South Korea.
Key people
Seong Hyeon Ahn
Chief Executive Officer, Director
Gil Su Lee
Chief Financial Officer, Managing Director
Su Cheol Park
Vice President, Director · since 2025
Managing Director
Cheol Su Park
Internal Auditor
Chun Rae Lee
Internal Auditor, Director · since 2023
Beom Jin Moon
Managing Director
Cheol Wu Shin
Chief Technology Officer, Vice President, Director
Han Gwon Kim
Non-Executive Independent Director
Jae Hui Park
Non-Executive Independent Director · since 2023
Hyeong Ho Seo
Non-Executive Independent Director
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||